Associate Chief of Staff for Research; Associate Professor
Nephrology
Dr. Robert B. Robey, MD
|
|
Give Review
Robert B. Robey is an expert in the field of Nephrology. He went to medical school at University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83/35 in Research/PrimaryCare. He received 2 awards: "Fellow (FAHA)" and "Fellow (FASN)". Robert Robey is also a published physician. He has 46 paper published. The most recent paper is: pH-dependent fluorescence of a heterologously expressed Aequorea green fluorescent protein mutant: in situ spectral characteristics and applicability to intracellular ...
Publications
- Designing a broad-spectrum integrative approach for cancer prevention and treatment.
- Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
- Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
- Varenicline for smoking reduction prior to cessation.
- Cyclical dehydration-induced renal injury and Mesoamerican nephropathy: as sweet by any other name?
- Peptides modeled on the RGG domain of AUF1/hnRNP-D regulate 3' UTR-dependent gene expression.
- Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
- "Does sunscreen promote hypertension?" and other questions. Novel interactions between vitamin D and the renin-angiotensin axis. Focus on "The world pandemic of vitami...
- Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease.
- Potassium levels after acute myocardial infarction.
- AUF1/hnRNP D represses expression of VEGF in macrophages.
- Hexokinase: a novel sugar kinase coupled to renal epithelial cell survival.
- Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.
- mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase k...
- Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.
- Does furosemide have a role in the management of hypercalcemia?
- Functional polymorphism of the Anpep gene increases promoter activity in the Dahl salt-resistant rat.
- Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.
- Mitochondrial hexokinases: guardians of the mitochondria.
- Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.
- Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance.
- Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix.
- Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases.
- Caveat experimentor: reporting expression profiling data involving multiple, functionally redundant isoforms.
- The role of phosphatidylinositol 3-kinase (PI3K) in CO2 stimulation of the Na+/HCO3- cotransporter (NBC).
- A central role for Pyk2-Src interaction in coupling diverse stimuli to increased epithelial NBC activity.
- LPA is a novel lipid regulator of mesangial cell hexokinase activity and HKII isoform expression.
- Angiotensin II stimulation of renal epithelial cell Na/HCO3 cotransport activity: a central role for Src family kinase/classic MAPK pathway coupling.
- Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol est...
- Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death.
- Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.
- SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO(3) cotransport activity in renal epithelial cells.
- Thrombin is a novel regulator of hexokinase activity in mesangial cells.
- Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway.
- Regulation of the renal Na-HCO(3) cotransporter. XI. Signal transduction underlying CO(2) stimulation.
- Basolateral Na(+)/HCO(3)(-) cotransport activity is regulated by the dissociable Na(+)/H(+) exchanger regulatory factor.
- pH-dependent fluorescence of a heterologously expressed Aequorea green fluorescent protein mutant: in situ spectral characteristics and applicability to intracellular ...
- Transient gene transfer into myotubes following differentiation in culture.
- Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene.
- Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin.
- Induction of the glucokinase gene by insulin in cultured neonatal rat hepatocytes. Relationship with DNase-I hypersensitive sites and functional analysis of a putative...
- Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity.
- Induction of glycinebetaine uptake into Xenopus oocytes by injection of poly(A)+ RNA from renal cells exposed to high extracellular NaCl.
- Renal Na-myo-inositol cotransporter mRNA expression in Xenopus oocytes: regulation by hypertonicity.
- Glucocorticoid induction of beta-adrenergic receptors in the DDT1 MF-2 smooth muscle cell line involves synthesis of new receptor.
Schools
University of Arkansas For Medical Sciences
Doctors Specialties
- Internal Medicine
- Nephrology
Accepted Insurances
Awards
- Fellow (FAHA)
- Fellow (FASN)
Education
-
Vanderbilt University -
National Institutes of Health Clinical Center -
University of Arkansas for Medical Sciences -
University of Arkansas for Medical Sciences College of Medicine
Drug Facts
| NPI NUMBER | 1710907001 | |
| NPPES Provider LastName | ROBEY | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 763083879 | |
| NPPES Provider State | TX | |
| Specialty Description | Physician Assistant | |
| Total Claim Count | 180.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710907001 |
| Last Name Of The Provider | ROBEY |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Lisa M. Schwartz, MD |
|
|
Dr. Kerry Vrakatitsis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Mansfield, MD |
|
|
Dr. Lynn L. Webster, MD |
|
|
Dr. Gregory W. Froehlich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hugh F. Huizenga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine Devine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brenda E. Sirovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda W. Ratliff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marybeth Durkin, MD |
|
|
Dr. Gregory S. Ogrinc, MD
This Doctor is OpenDoctor Recommended.
|